ID: ALA3781899

Max Phase: Preclinical

Molecular Formula: C9H10N2O

Molecular Weight: 162.19

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  NC1=N[C@@H](c2ccccc2)CO1

Standard InChI:  InChI=1S/C9H10N2O/c10-9-11-8(6-12-9)7-4-2-1-3-5-7/h1-5,8H,6H2,(H2,10,11)/t8-/m1/s1

Standard InChI Key:  ZBFPLELNWIASCT-MRVPVSSYSA-N

Associated Targets(Human)

Trace amine-associated receptor 1 1397 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 162.19Molecular Weight (Monoisotopic): 162.0793AlogP: 1.07#Rotatable Bonds: 1
Polar Surface Area: 47.61Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 6.74CX LogP: 1.46CX LogD: 1.38
Aromatic Rings: 1Heavy Atoms: 12QED Weighted: 0.67Np Likeness Score: 0.22

References

1. Galley G, Beurier A, Décoret G, Goergler A, Hutter R, Mohr S, Pähler A, Schmid P, Türck D, Unger R, Zbinden KG, Hoener MC, Norcross RD..  (2016)  Discovery and Characterization of 2-Aminooxazolines as Highly Potent, Selective, and Orally Active TAAR1 Agonists.,  (2): [PMID:26985297] [10.1021/acsmedchemlett.5b00449]

Source